MODA Technology Partners and Applied Biosystems team with XOMA for deployment of SQL*LIMS Micro/EM(TM) at Berkeley, CA Manufacturing Facilities

MODA Technology Partners (MODA), a software company that provides
mobile data acquisition solutions to the pharmaceutical manufacturing
industry, today announced that XOMA Ltd. (XOMA), has deployed SQL*LIMS
Micro/EM(TM) to automate environmental and utility monitoring and
processes at their biologics manufacturing facilities in Berkeley, CA.

XOMA, a leader in the discovery and development of antibody
therapeutics, has extensive experience manufacturing biologics for its
proprietary and partnered product programs. XOMA´s quality and
operational infrastructure enables the manufacture of product
candidates through every phase of product development in compliance
with cGMP using mammalian and microbial systems. Ric Reordan, XOMA´s
Manager of Microbiology, states that "Environmental and utility
monitoring are a critical part of our QC program. As part of our
manufacturing activities, we are required to provide a contaminant
free environment for the production of a wide range of therapeutic
products. With SQL*LIMS Micro/EM, we have transformed our
environmental and utility monitoring program to a paperless operation.
Improvements in productivity and compliance enable my team to focus on
high value science-based activity rather than administrative
paperwork. And ultimately this enhances XOMA´s manufacturing
operations."

Applied Biosystems has partnered with MODA Technology Partners to
expand the SQL*LIMS(R) product line with SQL*LIMS Micro/EM(TM), a
revolutionary solution combining paperless, mobile data acquisition
with unparalleled data visualization and analysis capabilities. Frank
Bernard, XOMA´s Senior IT Manager explains, "The SQL*LIMS Micro/EM
package enabled us to achieve certain efficiencies. We were able to go
into production within four months versus an alternative of eighteen
months for a solution requiring customization. Support and
administration are greatly simplified with a single, unified platform
for QA and QC users. And our user community loves the functionality
and efficiencies gained in their processes."

"We are very excited to extend our SQL*LIMS implementation at XOMA
with SQL*LIMS Micro/EM", states Peter Boogaard, Director of LIMS
Product Management and LIMS Global Marketing at Applied Biosystems.
"Our partnership with MODA enables us to better serve our client needs
with an integrated solution for quality assurance and quality control.
We are very pleased that XOMA is already benefiting from this
solution."

David Lipson, MODA´s CEO and Chairman, stated, "We are proud that
MODA products power the SQL*LIMS Micro/EM solution and we are
confident that this solution will help ensure that a first class
environmental monitoring program is maintained for all of XOMA´s
extensive manufacturing processes."

About XOMA

XOMA is a leader in the discovery, development and manufacture of
therapeutic antibodies. The Company´s expanding pipeline includes XOMA
052, an anti-IL-1 beta antibody, and XOMA 629, a synthetic peptide
compound derived from bactericidal/permeability-increasing protein.

XOMA´s proprietary development pipeline is primarily funded by
multiple revenue streams resulting from the licensing of its antibody
technologies, product royalties, development collaborations, and
biodefense contracts. XOMA´s technologies and experienced team have
contributed to the success of marketed antibody products, including
RAPTIVA(R) (efalizumab) for chronic moderate to severe plaque
psoriasis and LUCENTIS(R) (ranibizumab injection) for wet age-related
macular degeneration.

The Company has a premier antibody discovery and development
platform that incorporates leading antibody phage display libraries
and XOMA´s proprietary Human Engineering(TM) and bacterial cell
expression (BCE) technologies. BCE is a key breakthrough biotechnology
for the discovery and manufacturing of antibodies and other proteins.
As a result, more than 50 pharmaceutical and biotechnology companies
have signed BCE licenses.

In addition to developing its own products, XOMA develops products
for premier pharmaceutical companies including Novartis AG,
Schering-Plough Research Institute and Takeda Pharmaceutical Company
Limited. XOMA has a fully integrated product development
infrastructure, extending from pre-clinical science to product launch,
and a team of 300 employees at its Berkeley location. For more
information, please visit http://www.xoma.com.

About MODA Technology Partners

MODA Technology Partners (MODA) is a commercial software company
whose primary focus is addressing the growing need for effective
automation and efficient regulatory compliance within pharmaceutical
manufacturing. MODA´s solution leverages mobile computing technology
to help their clients increase operational efficiency, improve quality
and reduce manufacturing costs. Additional information is available at
www.modatp.com.